Loading clinical trials...
Loading clinical trials...
Pilot Study for the Use of Shortened Preemptive Therapy With Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney, Heart, Lung and/or Pancreas) of Hepatitis C Viremic Donors
Conditions
Interventions
Mavyret
Locations
1
United States
Mayo Clinic in Arizona
Phoenix, Arizona, United States
Start Date
September 10, 2020
Primary Completion Date
November 1, 2025
Completion Date
November 1, 2026
Last Updated
December 17, 2025
NCT06059664
NCT06953479
NCT06958796
NCT04162938
NCT07096453
NCT07195032
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions